Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sustained Release Naproxen vs Aleve
NCT02549469Phase 1Completed
- Sponsor
- Bayer
- Start
- Mar 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Aprol in pain (4 arms), sponsored by Bayer. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve 0-24h and 8 more. Started Mar 2007; status: completed.
02
Drugs
Aprol
03
Conditions
pain
Beyond the preview
Go deeper on NCT02549469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549469.